1244 related articles for article (PubMed ID: 25194808)
21. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
Paluszczak J; Baer-Dubowska W
Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
23. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
Gerhauser C
Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
[TBL] [Abstract][Full Text] [Related]
24. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
25. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
26. Epigenetics, disease, and therapeutic interventions.
Lu Q; Qiu X; Hu N; Wen H; Su Y; Richardson BC
Ageing Res Rev; 2006 Nov; 5(4):449-67. PubMed ID: 16965942
[TBL] [Abstract][Full Text] [Related]
27. Cancer epigenomics: DNA methylomes and histone-modification maps.
Esteller M
Nat Rev Genet; 2007 Apr; 8(4):286-98. PubMed ID: 17339880
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
Li LC; Carroll PR; Dahiya R
J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic alternations and cancer chemotherapy response.
Lv JF; Hu L; Zhuo W; Zhang CM; Zhou HH; Fan L
Cancer Chemother Pharmacol; 2016 Apr; 77(4):673-84. PubMed ID: 26707728
[TBL] [Abstract][Full Text] [Related]
30. Retrospective and perspective of plant epigenetics in China.
Duan CG; Zhu JK; Cao X
J Genet Genomics; 2018 Nov; 45(11):621-638. PubMed ID: 30455036
[TBL] [Abstract][Full Text] [Related]
31. Cancer type-specific epigenetic changes: gastric cancer.
Calcagno DQ; de Arruda Cardoso Smith M; Burbano RR
Methods Mol Biol; 2015; 1238():79-101. PubMed ID: 25421656
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and therapeutic applications of epigenetics.
Miyamoto K; Ushijima T
Jpn J Clin Oncol; 2005 Jun; 35(6):293-301. PubMed ID: 15930038
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic changes in solid and hematopoietic tumors.
Toyota M; Issa JP
Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
[TBL] [Abstract][Full Text] [Related]
34. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
35. [Lung cancer and its epigenetics association with chronic obstructive pulmonary disease].
Xu PW; Jin YT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):70-3. PubMed ID: 23450484
[TBL] [Abstract][Full Text] [Related]
36. Aberrant epigenetic landscape in cancer: how cellular identity goes awry.
Berdasco M; Esteller M
Dev Cell; 2010 Nov; 19(5):698-711. PubMed ID: 21074720
[TBL] [Abstract][Full Text] [Related]
37. Alterations in histone H4 lysine 20 methylation: implications for cancer detection and prevention.
Koturbash I; Simpson NE; Beland FA; Pogribny IP
Antioxid Redox Signal; 2012 Jul; 17(2):365-74. PubMed ID: 22035019
[TBL] [Abstract][Full Text] [Related]
38. [Epigenetics and cancer].
Deltour S; Chopin V; Leprince D
Med Sci (Paris); 2005 Apr; 21(4):405-11. PubMed ID: 15811306
[TBL] [Abstract][Full Text] [Related]
39. [Acquired disorders and epigenetics].
Ushijima T
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1645-9. PubMed ID: 20841925
[TBL] [Abstract][Full Text] [Related]
40. Clinical implications of epigenetic alterations in human thoracic malignancies: epigenetic alterations in lung cancer.
Shinjo K; Kondo Y
Methods Mol Biol; 2012; 863():221-39. PubMed ID: 22359296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
